Western Australian Therapeutics Advisory Group (WATAG)

The Western Australian Therapeutics Advisory Group (WATAG) promotes rational therapeutic drug use and provides independent advice to health professionals and health services on issues relating to the use of drugs and therapeutics in Western Australian public hospitals and the wider community.

WATAG has representation on the Council for Australia Therapeutic Advisory Groups (CATAG). The function of CATAG is to enable interjurisdictional communication, information sharing and collaboration to develop nationally consistent positions that promote the optimum use of medicines in hospitals.

• View the Terms of Reference of WATAG (PDF 417KB)

The WATAG subcommittees include:

• Western Australian Medicines Evaluation Panel (WAMEP) 

• Western Australian Committee for Antimicrobials (WACA)

Recommended Toxicology Critical Medicine Stockholding

The WA Antidotes Stockholdings List provides a general indication of availability of specific antidotes and antivenoms across WA hospitals. To verify actual stock at any particular time, and to access stock for emergency situations, please contact the individual site directly. The information on the list and the accompanying administration guidelines are reviewed and endorsed by the WA Toxicology Critical Medicines Expert Advisory Group. The list must not be relied on or used solely as a substitute for seeking advice from a qualified health practitioner. It is the user’s responsibility to verify the accuracy of the information provided.

Further information is currently available on Formulary One (external site)under ‘Useful Links and Contacts’ public hospital access only.